BioCatch vs Anduril

By valuation, Anduril is the larger company at $30.5B versus $1.3B — a 23.5x difference. Size can also be measured by team: BioCatch employs 100-500 people while Anduril has 4,000 employees.

Anduril has raised more in total funding at $8.2B, compared to BioCatch's $213M — a gap of $8B. Combined, the two companies have completed 3 known funding rounds.

Anduril leads with an Awaira Score of 92/100, while BioCatch sits at 80/100. That 12-point gap reflects real differences in funding, scale, and traction — it's not a vanity metric.

BioCatch was founded by Avi Turgeman in 2011. Anduril was founded by Palmer Luckey in 2017. Visit each company's profile on Awaira for a full founder biography.

BioCatch: BioCatch provides behavioural biometrics and fraud prevention AI that analyses how users physically interact with digital devices — mouse movements, typing cadence, touch pressure, and navigation patterns — to authenticate genuine users and detect account takeover, social engineering, and application fraud in real time during banking and financial transactions. The Tel Aviv company processes behavioural signals from hundreds of millions of user sessions monthly, building individual profiles that flag deviations indicating fraud.\n\nThe company raised approximately $213 million in venture funding including a Series D led by Tiger Global, reaching a valuation exceeding $1 billion. BioCatch counts over 30 tier-one banks globally among its clients including American Express, NatWest, and Lloyds Banking Group, with deployments protecting online banking and mobile banking sessions from fraud that bypasses traditional authentication controls. The platform is particularly effective against malware-assisted fraud and social engineering scams where the genuine account holder is unknowingly manipulated.\n\nBioCatch competes in the behavioural biometrics and fraud intelligence market alongside ThreatMetrix (now LexisNexis Risk Solutions), Sift, and Sardine, as well as traditional fraud management platforms from FICO and SAS. Its differentiation is the depth of its behavioural feature engineering from passive interaction signals that do not require active user participation, creating a fraud layer that operates continuously without adding friction to legitimate user journeys. The growing prevalence of authorised push payment fraud and social engineering attacks in European banking has expanded the relevant use case for BioCatch beyond traditional account takeover detection. Anduril: Anduril Industries builds autonomous defense systems powered by artificial intelligence. Founded by Palmer Luckey, the company develops hardware and software for national security applications, including autonomous drones, surveillance towers, and command-and-control platforms. Anduril Lattice OS serves as the backbone of its defense technology stack, enabling real-time decision-making across military domains. The company has secured major contracts with the U.S. Department of Defense and allied nations, positioning itself as a next-generation defense contractor challenging legacy primes like Lockheed Martin and Raytheon. Anduril operates manufacturing facilities in the United States and has expanded its workforce to support growing government demand for AI-enabled defense capabilities.

BioCatch got there first, launching in 2011 — that's 6 years of extra runway. Anduril didn't arrive until 2017. In AI, that kind of head start means more training data, deeper customer relationships, and a bigger talent moat.

BioCatch has about 100-500 employees; Anduril has about 4,000. A bigger team usually means more revenue or heavier VC backing, but in AI, small teams can build at massive scale.

Yes — they're direct rivals. Both BioCatch and Anduril compete in AI Security, targeting many of the same buyers. If you're evaluating one, you should be looking at the other.